Siam Capital
30 Park Place, New York, NY, 10007, United States
Overview
Siam Capital is an investment firm focused on the intersection of sustainability, consumer, and technology, in search of innovation that betters people and planet.
- Total investments
- 4
- Lead investments
- 2
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Finance
- Venture Capital
Investment portfolio
- Helaina
Participated · Series B · Sep 2024
Helaina develops human-equivalent bioactive proteins via a precision fermentation platform, commercializing effera™ Human Lactoferrin as its first ingredient. Effera™ is sold to consumer brands and through strategic distribution partners and will appear in products from Kroma Wellness, The Feed, Levelle Nutrition, Healthgevity and via Mitsubishi International Food Ingredients, Inc. The company positions effera™ to support iron homeostasis, metabolism, a balanced immune response and a beneficial microbiome, and clinical and pre-clinical research reportedly shows it is more effective than bovine lactoferrin; a study will soon be published in a peer-reviewed journal. Helaina plans to scale availability of effera™ for women’s health, active nutrition and healthy aging, and is working toward a future launch of infant formula in partnership with formula manufacturers. The company was founded in 2019 and is based in New York City. Helaina develops a human milk‑equivalent infant milk using precision fermentation that programs yeast to produce proteins nearly identical to those in human breast milk. Founded in 2019 by food scientist Laura Katz, the company has produced its first protein and plans to recreate breast milk’s components one at a time. Its product is designed to provide calories and to help build immunity against fungal, bacterial and viral diseases. Helaina plans to scale manufacturing with partners and pursue U.S. Food and Drug Administration approval as it prepares for commercialization. The company intends to use its proteins across clinically proven consumer products to create a new “consumer immunology” category and aims to price products to be accessible. Its latest financing supports capability growth, executive hires and finalizing go‑to‑market plans.
- Cowboy
Led · Series C · Jan 2022
Cowboy is a Brussels-based e-bike manufacturer best known for its digitally connected urban bicycles that integrate proprietary software, data-driven features and over-the-air updates. The company serves a community of more than 80,000 riders and maintains in-house design, engineering and software teams to iterate on its award-winning hardware-software platform. Following recent operational challenges, Cowboy is partnering with French mobility group ReBirth to leverage its industrial capacity, supply-chain reach and 95 Oxygen/10 Ovelo stores plus 500 independent dealers in France. Production will restart at ReBirth’s French assembly site with a plan to build over 1,500 bikes in January and significantly scale capacity through 2026. The integration is expected to shorten lead times, improve quality control and bolster after-sales support while keeping Cowboy’s brand and R&D independent. Financially, the company has restructured its balance sheet, converted legacy obligations to equity, and secured fresh funding to stabilise operations. These measures aim to restore delivery reliability, expand retail presence—especially in France, currently its fourth-largest market—and move the business toward sustainable profitability.
- Stack Moxie
Participated · Seed · Jul 2021
Stack Moxie builds a monitoring and testing automation platform for enterprise tech stacks. The company was founded in 2018 and is headquartered in Seattle. It has leaned on multiple startup support programs, including SaaS Launch Lab (a joint project of M12 and Project W), Seattle Techstars 2019, Women in Cloud and the WTIA Founders program. The startup reported significant revenue growth and doubled its number of customers in the first half of 2021, with existing customers expanding usage. Stack Moxie’s team includes CEO and founder M.H. Lines and 12 other employees, and leadership roles in sales, product engineering and customer success. The company has early enterprise customers and continued product development following initial onboarding and feature expansion.
Team
No current team members are available.